Core Insights - Huaying Medical, a company specializing in ultrasound technology, has completed a new round of financing led by Nanshan Venture Capital, with participation from existing shareholder Shanghai Ke Investment Co., Ltd. and exclusive financial advisory from Haoyue Capital [1] - Founded in 2020 and incubated by the Shenzhen Institute of Advanced Technology, Huaying Medical possesses proprietary technologies in ultrasound transducers, active interventional catheters, and high-frequency ultrasound imaging systems, making it one of the few companies capable of mastering the entire ultrasound technology chain [1][4] - The company has a strong technical foundation, with its founder Dr. Qiu being an expert in ultrasound engineering and a background in top global ultrasound laboratories, contributing to the development of several commercially successful ultrasound products in China [1][4] Product Development - Huaying Medical has completed the product development of 4D-ICE, which enhances 2D imaging with real-time 3D visualization, significantly improving the visualization of structural heart procedures and lowering the threshold for doctors [2] - The company has mastered the complete core technology for 4D-ICE, including imaging probes, multi-directionally adjustable catheters, 4D imaging algorithms, and imaging hosts, aiming to provide the highest cost-performance 4D intracardiac imaging solutions globally [2] Market Position and Future Prospects - Huaying Medical is breaking the import monopoly in the ultrasound field, achieving breakthroughs in various areas such as upgraded ultrasound liquid handling devices, small animal high-frequency ultrasound imaging equipment, programmable ultrasound imaging devices, and photoacoustic multimodal imaging devices, with several being national exclusives or firsts [4] - Investors express confidence in Huaying Medical's potential, highlighting the team's strong technical accumulation and diverse product pipeline, which includes interventional catheter consumables and main equipment, mitigating future development limitations [6] - The company is well-positioned to respond positively to the domestic bulk procurement environment, providing significant benefits to patients with its core products [6]